Homoharringtonine is a safe and effective substitute for anthracyclines in children younger than 2 years old with acute myeloid leukemia

所属期刊栏目：13

资助基金：This work was partially supported by the National Natural Science Foundation of China81270623;the Science and Technology Commission of Shanghai Municipality14411950600;the Public Health 3-Year Project of Shanghai Children”s Medical CenterGWIV-25

在线出版日期：2019-07-04（万方平台首次上网日期，不代表论文的发表时间）

页数：共10页

页码：378-387